Total operating revenue was a record $2.02 billion, an increase of 16% from the prior financial year.

Medicare beneficiaries who initiated PAP saved $195 in per-member per-month costs over 24 months.

In Oct 2024, the OIG announced that it is focusing on Medicare payments to DME suppliers for oxygen and oxygen equipment.

Medtrade exhibitor Resmed has acquired Medtrade exhibitor VirtuOx, an independent diagnostic testing facility (IDTF) for sleep, respiratory, and cardiac conditions.

If some patients are covered by Medicare, suppliers need to be aware of the federal laws governing such arrangements.

Medtrade exhibitor Resmed has launched NightOwl™, a new home sleep apnea test.